Description

Tesamorelin reduces visceral fat, improves body composition, supports metabolic health, and may enhance cognitive function by stimulating natural growth hormone release.

Key Benefits

1. Visceral Fat Reduction

Tesamorelin is FDA-approved for reducing excess abdominal fat in HIV-positive patients with lipodystrophy. Clinical trials show it can reduce visceral adipose tissue by up to 18% over 26 weeks, targeting deep belly fat without affecting subcutaneous fat

This selective fat reduction is significant for both cosmetic and metabolic health.

2. Improved Body Composition

By stimulating the pituitary to release growth hormone naturally, tesamorelin increases IGF-1 levels, which supports lean muscle retention and skeletal muscle growth

This makes it useful for body recomposition, bodybuilding, and recovery from intense training.

3. Metabolic Health Support

Tesamorelin enhances lipid profiles, reduces hepatic fat, and improves insulin sensitivity indirectly by maintaining physiological GH pulses rather than continuous exogenous GH exposure

This helps reduce metabolic risk factors associated with visceral fat accumulation.

4. Cognitive Function Enhancement

Research indicates that tesamorelin may improve executive function, verbal memory, and visual memory in adults, including those with mild cognitive impairment, likely through IGF-1-mediated effects on the brain

This suggests potential benefits for aging populations seeking cognitive support.

5. Safer Hormonal Regulation

Unlike direct HGH injections, tesamorelin works upstream by stimulating the pituitary gland, preserving natural feedback loops and pulsatile GH release. This reduces the risk of supraphysiological IGF-1 levels and associated side effects

6. Liver Health

Studies have shown that tesamorelin can reduce hepatic fat fraction by up to 37% over 12 months, which may support liver function, particularly in individuals recovering from anabolic steroid use or metabolic stress